申请人:SELVITA S.A.
公开号:US20180148429A1
公开(公告)日:2018-05-31
The present invention relates to substituted quinoxaline derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.